Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cellular characterization of leukotoxin diol-induced mitochondrial dysfunction.

M F Sisemore1, J Zheng, J C Yang

  • 1Department of Entomology, University of California, Davis, California 95616, USA.

Archives of Biochemistry and Biophysics
|July 27, 2001
PubMed
Summary

Leukotoxin diol, a metabolite of leukotoxin, causes cell death by disrupting mitochondrial function. Cyclosporin A protects against this toxicity, suggesting a therapeutic target for acute respiratory distress syndrome.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU), a soluble epoxide hydrolase inhibitor, lowers L-NAME-induced hypertension through suppression of angiotensin-converting enzyme in rats.

European review for medical and pharmacological sciences·2020
Same author

Addition of milk fat globule membrane-enriched supplement to a high-fat meal attenuates insulin secretion and induction of soluble epoxide hydrolase gene expression in the postprandial state in overweight and obese subjects.

Journal of nutritional science·2019
Same author

Soluble epoxide hydrolase inhibitor promotes immunomodulation to inhibit bone resorption.

Journal of periodontal research·2018
Same author

Effect of angiotensin-converting enzyme blockade, alone or combined with blockade of soluble epoxide hydrolase, on the course of congestive heart failure and occurrence of renal dysfunction in Ren-2 transgenic hypertensive rats with aorto-caval fistula.

Physiological research·2018
Same author

Metabolic/inflammatory/vascular comorbidity in psychiatric disorders; soluble epoxide hydrolase (sEH) as a possible new target.

Neuroscience and biobehavioral reviews·2018
Same author

Pharmacokinetics and antinociceptive effects of the soluble epoxide hydrolase inhibitor t-TUCB in horses with experimentally induced radiocarpal synovitis.

Journal of veterinary pharmacology and therapeutics·2017

Area of Science:

  • Biochemistry
  • Cell Biology
  • Toxicology

Background:

  • Leukotoxin, a linoleic acid epoxide, is linked to acute respiratory distress syndrome.
  • Leukotoxin diol formation by epoxide hydrolase is a hypothesized activation step.

Purpose of the Study:

  • To investigate the role of mitochondria in leukotoxin diol toxicity.
  • To determine if leukotoxin diol activates the mitochondrial permeability transition.

Main Methods:

  • Assessed cellular toxicity of leukotoxin diol in human and insect cells.
  • Evaluated mitochondrial integrity using cell- and organelle-based assays.
  • Examined the effect of cyclosporin A on leukotoxin diol toxicity in vitro and in vivo.

Main Results:

Related Experiment Videos

  • Leukotoxin diol induced acute cellular toxicity.
  • Leukotoxin diol specifically activated the mitochondrial permeability transition, leading to cytochrome c release and cell death.
  • Cyclosporin A inhibited these toxic effects and reduced in vivo toxicity.

Conclusions:

  • Leukotoxin diol disrupts mitochondrial function via the mitochondrial permeability transition.
  • This pathway represents a key mechanism in leukotoxin-induced cellular toxicity.
  • Targeting the mitochondrial permeability transition may offer a therapeutic strategy for leukotoxin-related conditions.